EXPLEOSOL vs GENESYS: Stock Comparison
EXPLEO SOLUTIONS is the larger company by market capitalisation. EXPLEO SOLUTIONS shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
EXPLEOSOL leads 10; GENESYS leads 1 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | EXPLEOSOL | GENESYS |
|---|---|---|
| Sector | Information Technology | Information Technology |
| Industry | IT Enabled Services | IT Enabled Services |
Price
| Metric | EXPLEOSOL | GENESYS |
|---|---|---|
| Live Price | ₹801.4 | ₹171.15 |
| Day Change | -1.94% | -9.4% |
| Volume | 14,270 | 12.43 L |
| 52-Week High | ₹1,175.1 | ₹528 |
| 52-Week Low | ₹640 | ₹168.5 |
| Distance from 52W High | -31.8% | -67.59% |
Valuation
| Metric | EXPLEOSOL | GENESYS |
|---|---|---|
| Market Cap | ₹1,249 Cr | ₹1,149 Cr |
| P/E Ratio | 9.06x | 37.28x |
| P/B Ratio | 1.61x | 1.63x |
| EPS | ₹88.75 | ₹5.07 |
| Book Value | ₹500.21 | ₹173 |
| Dividend Yield | 13.75% | 0% |
Growth
| Metric | EXPLEOSOL | GENESYS |
|---|---|---|
| Revenue Growth (TTM YoY) | 11.9% | 10.7% |
| EPS Growth (TTM YoY) | 73.2% | -35.9% |
| Qtr Sales Growth | 0% | 0% |
| Qtr Profit Growth | 0% | 0% |
Profitability & Leverage
| Metric | EXPLEOSOL | GENESYS |
|---|---|---|
| ROE | 15% | 4.65% |
| ROCE | 29.61% | 4.86% |
| Net Margin | 11.19% | 9.94% |
| Operating Margin | 14.38% | 17.99% |
| Debt to Equity | 0x | 0.23x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | EXPLEOSOL | GENESYS |
|---|---|---|
| Promoter Holding | 71.05% | 12.33% |
| FII Holding | 0.16%▲ 0.03 pp | 1.68%▲ 0.24 pp |
| DII Holding | 0.39%▲ 0.27 pp | 0.81%▲ 0.21 pp |
| Public Holding | 28.4%▼ 0.3 pp | 64.78%▼ 0.45 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: EXPLEO SOLUTIONS and GENESYS INTL CORPN.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.